Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Chronic obstructive pulmonary disease (COPD) is managed with personalized medication to ease symptoms and improve life quality.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Anti-Desmocollin 3 antibodies can cause pemphigus-like symptoms in mice.

Combining platelet-rich plasma injections and gel may effectively treat morphea, improving skin elasticity and reducing pain.

Treatment with methotrexate and prednisolone led to complete hair regrowth and no relapse for 2 years.

Infliximab may cause hair loss in Crohn's disease patients.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Fremanezumab effectively reduces migraines and improves quality of life with mild side effects.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

TPA is about 50 times more effective at promoting tumors than MZ.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Dermal EZH2 controls skin cell development and hair growth in mice.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Certain drugs can cause eyelid inflammation, so doctors should monitor and educate patients on eyelid care.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.